Minister for Health, Maria Larsson, referred the question to the National Board on Health and Welfare, the authority which has drafted the contract. According to the Board, the clause, which has not been made public, should not be seen to reflect badly upon the safety of the vaccine. Richard Bergström, the CEO of the trade association for the research-based pharmaceutical industry in Sweden, agrees. He says that as far as he knows Sweden has never agreed to such a clause before, but that it is not unusual when a vaccine has to be produced swiftly.
“Without that protection there would be no research into vaccines;” Bergström said to Swedish news agency TT.